{
  "ticker": "KYTX",
  "company_name": "Kyverna Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06475495",
      "title": "Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Rheumatoid Arthritis",
      "start_date": "2024-11",
      "completion_date": "2027-03",
      "enrollment": 0,
      "sponsor": "Charite University, Berlin, Germany"
    },
    {
      "nct_id": "NCT06193889",
      "title": "KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis",
      "status": "RECRUITING",
      "phase": "PHASE2, PHASE3",
      "condition": "Myasthenia Gravis, Generalized Myasthenia Gravis",
      "start_date": "2024-08-28",
      "completion_date": "2028-09",
      "enrollment": 0,
      "sponsor": "Kyverna Therapeutics"
    },
    {
      "nct_id": "NCT05938725",
      "title": "KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV",
      "start_date": "2023-04-28",
      "completion_date": "2027-08",
      "enrollment": 0,
      "sponsor": "Kyverna Therapeutics"
    },
    {
      "nct_id": "NCT06588491",
      "title": "KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Stiff-Person Syndrome, SPS",
      "start_date": "2024-09-25",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "Kyverna Therapeutics"
    },
    {
      "nct_id": "NCT06400303",
      "title": "KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Systemic Sclerosis, Systemic Sclerosis - Diffuse Cutaneous, Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria",
      "start_date": "2024-08-06",
      "completion_date": "2027-03",
      "enrollment": 0,
      "sponsor": "Kyverna Therapeutics"
    },
    {
      "nct_id": "NCT06152172",
      "title": "CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis, ANCA Associated Vasculitis",
      "start_date": "2024-08-05",
      "completion_date": "2026-02",
      "enrollment": 0,
      "sponsor": "David Porter"
    },
    {
      "nct_id": "NCT06590545",
      "title": "Anti-CD 19 CAR-T Cell Therapy in Patients with ANCA Vasculitis",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "ANCA-IgG-positive ANCA Associated Vasculitis",
      "start_date": "2025-01",
      "completion_date": "2027-07",
      "enrollment": 0,
      "sponsor": "David Simon"
    },
    {
      "nct_id": "NCT06384976",
      "title": "KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, MS",
      "start_date": "2024-09-20",
      "completion_date": "2029-01",
      "enrollment": 0,
      "sponsor": "Kyverna Therapeutics"
    },
    {
      "nct_id": "NCT06451159",
      "title": "A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Progressive Multiple Sclerosis",
      "start_date": "2024-06-20",
      "completion_date": "2027-02",
      "enrollment": 0,
      "sponsor": "Bruce Cree"
    },
    {
      "nct_id": "NCT06342960",
      "title": "KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Lupus Nephritis, Lupus Nephritis - WHO Class III, Lupus Nephritis - WHO Class IV",
      "start_date": "2022-12-01",
      "completion_date": "2029-01",
      "enrollment": 0,
      "sponsor": "Kyverna Therapeutics"
    }
  ],
  "summary": {
    "total_trials": 11,
    "by_phase": {
      "PHASE1, PHASE2": 5,
      "PHASE2, PHASE3": 1,
      "PHASE2": 2,
      "PHASE1": 3
    },
    "by_status": {
      "NOT_YET_RECRUITING": 2,
      "RECRUITING": 1,
      "ACTIVE_NOT_RECRUITING": 8
    },
    "active_trials": 9,
    "completed_trials": 0,
    "conditions": [
      "ANCA-IgG-positive ANCA Associated Vasculitis",
      "Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis, ANCA Associated Vasculitis",
      "Lupus Nephritis, Lupus Nephritis - WHO Class III, Lupus Nephritis - WHO Class IV",
      "Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV",
      "Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive",
      "Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, MS",
      "Myasthenia Gravis, Generalized Myasthenia Gravis",
      "Progressive Multiple Sclerosis",
      "Rheumatoid Arthritis",
      "Stiff-Person Syndrome, SPS",
      "Systemic Sclerosis, Systemic Sclerosis - Diffuse Cutaneous, Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:19:33.739813",
    "search_query": "Kyverna Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Kyverna+Therapeutics,+Inc."
  }
}